Condition
Pulmonary Arteriovenous Malformations
Total Trials
5
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (4)
Trial Status
Completed2
Unknown1
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06735976Not ApplicableRecruitingPrimary
Efficacy & Safety of LOBO™ Vascular Occlusion Device for Embolization of Pulmonary Arteriovenous Malformations
NCT02436213Not ApplicableCompletedPrimary
Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs
NCT01856842Not ApplicableCompletedPrimary
Reperfusion of Pulmonary Arteriovenous Malformations After Embolotherapy
NCT00733759WithdrawnPrimary
Contrast Echocardiography in Patients With Pulmonary Arteriovenous Malformations (PAVMs)
NCT02458703Not ApplicableUnknownPrimary
Cardiopulmonary Exercise Testing to Evaluate Pulmonary AVMs With and Without Airflow Obstruction
Showing all 5 trials